A researcher at Peking University's Beijing Advanced Innovation Center for Genomics conducting tests at their laboratory. - AFP
KUALA LUMPUR (The Straits Times/ANN): China's control of the base ingredients to make medicines gives the Asian giant leverage over the production of a coronavirus vaccine no matter who wins the global race to discover it.
A host of nations such as the United States, United Kingdom, France and Australia -- even Singapore and Malaysia are on the list -- are desperately pursuing a vaccine to end the pandemic that has infected nearly six million and killed more than 350,000 since December.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
